SLE also involves a number of cytokine pathways, including B lymphocyte stimulator (BLys), which promotes B-cell survival and autoantibody production, type I interferon (IFN), which acts as immune adjuvant, and tumor necrosis factor, which contributes to organ inflammation. Here, TNFSF13B is linked to systemic lupus erythematosus.